Structural basis for activation of the complement system by component C4 cleavage

被引:91
|
作者
Kidmose, Rune T. [1 ]
Laursen, Nick S. [1 ]
Dobo, Jozsef [3 ]
Kjaer, Troels R. [2 ]
Sirotkina, Sofia [1 ]
Yatime, Laure [1 ]
Sottrup-Jensen, Lars [1 ]
Thiel, Steffen [2 ]
Gal, Peter [3 ]
Andersen, Gregers R. [1 ]
机构
[1] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark
[2] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark
[3] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1113 Budapest, Hungary
基金
匈牙利科学研究基金会;
关键词
crystallography; pattern recognition; proteolysis; structural biology; MANNAN-BINDING LECTIN; CONTROL PROTEIN MODULES; RECOGNITION; REVEALS; DOMAIN; MASP-2; IDENTIFICATION; INHIBITORS; THIOESTER; ENZYME;
D O I
10.1073/pnas.1208031109
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
An essential aspect of innate immunity is recognition of molecular patterns on the surface of pathogens or altered self through the lectin and classical pathways, two of the three well-established activation pathways of the complement system. This recognition causes activation of the MASP-2 or the C1s serine proteases followed by cleavage of the protein C4. Here we present the crystal structures of the 203-kDa human C4 and the 245-kDa C4.MASP-2 substrate.enzyme complex. When C4 binds to MASP-2, substantial conformational changes in C4 are induced, and its scissile bond region becomes ordered and inserted into the protease catalytic site in a manner canonical to serine proteases. In MASP-2, an exosite located within the CCP domains recognizes the C4 C345C domain 60 angstrom from the scissile bond. Mutations in C4 and MASP-2 residues at the C345C-CCP interface inhibit the intermolecular interaction and C4 cleavage. The possible assembly of the huge in vivo enzyme-substrate complex consisting of glycan-bound mannan-binding lectin, MASP-2, and C4 is discussed. Our own and prior functional data suggest that C1s in the classical pathway of complement activated by, e. g., antigen-antibody complexes, also recognizes the C4 C345C domain through a CCP exosite. Our results provide a unified structural framework for understanding the early and essential step of C4 cleavage in the elimination of pathogens and altered self through two major pathways of complement activation.
引用
收藏
页码:15425 / 15430
页数:6
相关论文
共 50 条
  • [1] Structural basis for activation of the complement system by C4 cleavage
    Andersen, Gregers R.
    Kidmose, Rune T.
    Laursen, Nick S.
    Dobo, Jozsef
    Kjaer, Troels R.
    Sirotkina, Sofia
    Yatime, Laure
    Sottrup-Jensen, Lars
    Thiel, Steffen
    Gal, Peter
    IMMUNOBIOLOGY, 2012, 217 (11) : 1205 - 1205
  • [2] Structural basis for activation of the complement system by C4 cleavage
    Andersen, G. R.
    Kidmose, R. T.
    Laursen, N. S.
    Dobo, J.
    Kjaer, T. R.
    Sirotkina, S.
    Yatime, L.
    Sottrup-Jensen, L.
    Thiel, S.
    Gal, P.
    IMMUNOLOGY, 2012, 137 : 29 - 30
  • [3] Rapid activation of the complement system by cuprophane depends on complement component C4
    Lhotta, K
    Würzner, R
    Kronenberg, F
    Oppermann, M
    König, P
    KIDNEY INTERNATIONAL, 1998, 53 (04) : 1044 - 1051
  • [4] Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement
    Mortensen, Sofia
    Kidmose, Rune T.
    Petersen, Steen V.
    Szilagyi, Agnes
    Prohaszka, Zoltan
    Andersen, Gregers R.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (11): : 5488 - 5496
  • [5] Structural studies on human complement component C4
    Sirotkina, S.
    Andersen, G. R.
    MOLECULAR IMMUNOLOGY, 2013, 56 (03) : 316 - 316
  • [6] CLEAVAGE OF FOURTH COMPONENT OF HUMAN COMPLEMENT (C4) BY ACTIVATED CLS
    PATRICK, RA
    TAUBMAN, SB
    LEPOW, IH
    IMMUNOCHEMISTRY, 1970, 7 (02): : 217 - &
  • [7] Hepatitis C virus NS3/4A protease inhibits complement activation through cleavage of complement component C4
    Mawatari, Seiichi
    Uto, Hirofumi
    Sato, Yuko
    Kumagai, Kotaro
    Oda, Kohei
    Tabu, Kazuaki
    Ohno, Kaori
    Oshige, Akihiko
    Imanaka, Dai
    Tamai, Tsutomu
    Moriuchi, Akihiro
    Oketani, Makoto
    Ido, Akio
    Suzuki, Tetsuro
    Tsubouchi, Hirohito
    HEPATOLOGY, 2012, 56 : 706A - 706A
  • [8] THE COMPLEMENT COMPONENT C4 OF MAMMALS
    DODDS, AW
    LAW, SKA
    BIOCHEMICAL JOURNAL, 1990, 265 (02) : 495 - 502
  • [9] THE STRUCTURAL VARIANTS OF COMPLEMENT COMPONENT (C4) IN THE RISK AND CLINICAL CHARACTERISTICS OF SCHIZOPHRENIA
    Chen, Cheng Cheng
    Woo, Julia
    Pouget, Jennie
    Zai, Clement
    Kennedy, James
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S207 - S207
  • [10] COMPLEMENT COMPONENT (C4) STRUCTURAL VARIANTS IN THE RISK AND CLINICAL CHARACTERISTICS OF SCHIZOPHRENIA
    Chen, Cheng
    Woo, Julia
    Pouget, Jennie
    Zai, Clement
    Kennedy, James L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1331 - 1331